Daniel E. Ryweck

Chief Financial Officer, Panbela Therapeutics, Inc.

Companies

Silo Pharma, Inc.Chief financial officer Oct 4, 2022 to now¹
KonaTel, Inc.Board member Jul 18, 2016 to Aug 2, 2017²
Panbela Therapeutics, Inc.Chief financial officer Sep 14, 2015 to Sep 14, 2015³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Silo Pharma, Inc. SILO5,000 shares⁴$5.8K at $1.15May 26, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

May 26, 2023Bought 1,000 shares at $2.13 of Silo Pharma, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARSilo Pharma, Inc., Chief financial officer
2
SEC EDGARKonaTel, Inc., Board member
3
SEC EDGARPanbela Therapeutics, Inc., Chief financial officer
4
SEC EDGARSilo Pharma, Inc. shares after the filing of May 26, 2023